| Dr Brian Peter Bjerke, MD | |
|
4010 W 65th St, Edina, MN 55435-1706 | |
| (952) 456-7000 | |
| (952) 456-7001 |
| Full Name | Dr Brian Peter Bjerke |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 17 Years |
| Location | 4010 W 65th St, Edina, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043445612 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 55026 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Infinite Health Collaborative Pa | 1052225042 | 772 |
News Archive
Merck, known as MSD outside the United States and Canada, today provided an update on the development program for MK-8931, a novel investigational oral β-amyloid precursor protein site-cleaving enzyme (BACE) inhibitor.
In laboratory mouse experiments, researchers at The University of Texas M. D. Anderson Cancer Center have developed a way to use RNA interference (RNAi) so that it permanently hampers breast cancer development. The technique permanently silences activated STAT3, a crucial gene found in some human breast tumors, thus reducing the cancer's ability to become invasive.
The bowel cancer screening programme, which detects early signs of the disease, has been launched in Northern Ireland.
A new pilot study compared the use of human breast milk to formula in children less than 5 years of age who underwent bone marrow transplant (BMT), measuring the levels of inflammatory and pro-inflammatory biomarkers in the stool and blood to assess inflammatory injury to the intestinal microbiome.
Gadonanotubes (GNTs) developed at Rice University are beginning to show positive results in a study funded by a federal stimulus grant through the National Institutes of Health (NIH) last year.
› Verified 7 days ago
| Entity Name | Infinite Health Collaborative Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164474250 PECOS PAC ID: 1052225042 Enrollment ID: O20040209000574 |
News Archive
Merck, known as MSD outside the United States and Canada, today provided an update on the development program for MK-8931, a novel investigational oral β-amyloid precursor protein site-cleaving enzyme (BACE) inhibitor.
In laboratory mouse experiments, researchers at The University of Texas M. D. Anderson Cancer Center have developed a way to use RNA interference (RNAi) so that it permanently hampers breast cancer development. The technique permanently silences activated STAT3, a crucial gene found in some human breast tumors, thus reducing the cancer's ability to become invasive.
The bowel cancer screening programme, which detects early signs of the disease, has been launched in Northern Ireland.
A new pilot study compared the use of human breast milk to formula in children less than 5 years of age who underwent bone marrow transplant (BMT), measuring the levels of inflammatory and pro-inflammatory biomarkers in the stool and blood to assess inflammatory injury to the intestinal microbiome.
Gadonanotubes (GNTs) developed at Rice University are beginning to show positive results in a study funded by a federal stimulus grant through the National Institutes of Health (NIH) last year.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Peter Bjerke, MD 4200 Dahlberg Dr, Suite 300, Golden Valley, MN 55422-4840 Ph: (952) 512-5600 | Dr Brian Peter Bjerke, MD 4010 W 65th St, Edina, MN 55435-1706 Ph: (952) 456-7000 |
News Archive
Merck, known as MSD outside the United States and Canada, today provided an update on the development program for MK-8931, a novel investigational oral β-amyloid precursor protein site-cleaving enzyme (BACE) inhibitor.
In laboratory mouse experiments, researchers at The University of Texas M. D. Anderson Cancer Center have developed a way to use RNA interference (RNAi) so that it permanently hampers breast cancer development. The technique permanently silences activated STAT3, a crucial gene found in some human breast tumors, thus reducing the cancer's ability to become invasive.
The bowel cancer screening programme, which detects early signs of the disease, has been launched in Northern Ireland.
A new pilot study compared the use of human breast milk to formula in children less than 5 years of age who underwent bone marrow transplant (BMT), measuring the levels of inflammatory and pro-inflammatory biomarkers in the stool and blood to assess inflammatory injury to the intestinal microbiome.
Gadonanotubes (GNTs) developed at Rice University are beginning to show positive results in a study funded by a federal stimulus grant through the National Institutes of Health (NIH) last year.
› Verified 7 days ago
Stefano M Sinicropi, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7373 France Ave S Ste 408, Edina, MN 55435 Phone: 651-430-3800 Fax: 651-430-1447 | |
Gregory John Folsom, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 W 78th St, Edina, MN 55439 Phone: 952-946-9777 | |
Douglas Albert Drake, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4010 W 65th St, Edina, MN 55435 Phone: 952-456-7000 Fax: 952-456-7001 | |
Rodney Holmes Peterson, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3250 W 66th St, Suite 100, Edina, MN 55435 Phone: 952-920-0970 Fax: 952-922-1605 | |
Kayvon Scott Riggi, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4010 W 65th St, Edina, MN 55435 Phone: 952-456-7000 Fax: 952-456-7001 | |
Dr. Maryclare Kearns Mccarthy, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4010 W 65th St, Edina, MN 55435 Phone: 952-835-0750 Fax: 952-835-0662 |